RUA Life Sciences PLC Result of AGM (2528K)
23 Agosto 2023 - 5:18PM
UK Regulatory
TIDMRUA
RNS Number : 2528K
RUA Life Sciences PLC
23 August 2023
23 August 2023
RUA Life Sciences plc
("RUA" the "Company" or the "Group")
Result of AGM
RUA Life Sciences plc (AIM:RUA.L), the holding company of a
group of medical device businesses focussed on the exploitation of
the world's leading long-term implantable biostable polymer
(Elast-Eon (TM)), announces that all resolutions put forward to its
Annual General Meeting held earlier today were duly passed and the
votes cast were as follows:
Res Votes Votes Votes Votes
No. For % Against % Total % I.S.C. Withheld
1 3,120,357 100.00% 0 0.00% 3,120,357 14.07 0
---------- -------- --------- ------- ---------- --------- ----------
2 2,229,757 71.48% 889,792 28.52% 3,119,549 14.06 808
---------- -------- --------- ------- ---------- --------- ----------
3 2,955,917 95.24% 147,790 4.76% 3,103,707 13.99 16,650
---------- -------- --------- ------- ---------- --------- ----------
4 2,951,476 95.23% 147,790 4.77% 3,099,266 13.97 21,091
---------- -------- --------- ------- ---------- --------- ----------
5 3,093,484 99.67% 10,223 0.33% 3,103,707 13.99 16,650
---------- -------- --------- ------- ---------- --------- ----------
6 2,980,778 95.53% 139,356 4.47% 3,120,134 14.06 223
---------- -------- --------- ------- ---------- --------- ----------
7 2,980,448 95.53% 139,569 4.47% 3,120,017 14.06 340
---------- -------- --------- ------- ---------- --------- ----------
8 2,951,597 95.48% 139,569 4.52% 3,091,166 13.93 29,191
---------- -------- --------- ------- ---------- --------- ----------
The full text of each of the resolutions is set out in the
notice of Annual General Meeting, copies of which are available on
the Company's website (www.rualifesciences.com).
QCA Code - statement regarding voting result
The board notes that although Resolution 2 (remuneration
committee report) passed with the requisite majority, it received
more than 20% of votes against the board's recommendation. We thank
shareholders for their support and the Board will look to continue
engagement throughout the year. The board encourages an open and
constructive dialogue directly with shareholders and continue to be
willing to engage with any shareholder on any relevant topics
should they so wish.
For further information contact:
RUA Life Sciences
Bill Brown, Chairman Tel: +44 (0)1294 317073
Dr Caroline Stretton, Group MD Tel: +44 (0)1294 317073
Cenkos Securities plc (Nominated Adviser and Broker) Tel: +44 (0)20 7397 8900
Giles Balleny / Max Gould (Corporate Finance)
Michael Johnson (Sales)
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGPJMATMTBTBAJ
(END) Dow Jones Newswires
August 23, 2023 11:18 ET (15:18 GMT)
Grafico Azioni Rua Life Sciences (LSE:RUA)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Rua Life Sciences (LSE:RUA)
Storico
Da Mag 2023 a Mag 2024